1. Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases.
- Author
-
Ruschulte, Heiner, Shi, Serena, Tseng, William W., Kolodzie, Kerstin, Philip C Crawford, Philip C., Schneider, Darren B., Kashani-Sabet, Mohammed, Minor, David, Apfel, Christian, and Leong, Stanley P. L.
- Subjects
- *
ANTINEOPLASTIC agents , *MELANOMA treatment , *NITROGEN mustards , *ANESTHESIA , *HEMODYNAMICS , *PERFUSION , *RESEARCH funding , *DATA analysis software , *THERAPEUTICS - Abstract
Background: Hyperthermic isolated limb perfusion (HILP) is used for patients with intractable or extensive in-transit metastatic melanoma of the limb to deliver high concentrations of cytotoxic agents to the affected limb and offers a treatment option in a disease stage with a poor prognosis when no treatment is given. Methods: In a retrospective chart review of 17 cases, we studied the anesthetic and hemodynamic changes during HILP and its management. Results: HILP was well tolerated except in one case that is described herein. We present summary data of all cases undergoing upper and lower limb perfusion, discuss our current clinical practice of preoperative, perioperative and intraoperative patient care including the management of HILP circuit. Conclusion: HILP is a challenging procedure, and requires a team effort including the surgical team, anesthesia care providers, perfusionists and nurses. Intraoperatively, invasive hemodynamic and metabolic monitoring is indispensable to manage significant hemodynamic and metabolic changes due to fluid shifts and release of cytokines. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF